GlaxoSmithKline creates a new operating unit dedicated to expanding access to medicines for people living in the world’s poorest countries
As part of its commitment to further transform the companys approach to diseases that disproportionately affect the world's poorest people.
Read the full article16y agoen
You might also wanna read
OpenAI No. 2 Executive Fidji Simo Steps Down from Full-Time Role to Focus on Health Recovery
Why ambulance rides in the US are so expensive: The broken economics of emergency medical transport
Moderna's mResvia gets shot in the arm from EU contract
pharmaphorum·7h ago

Australia news live: Hanson defends UK ‘fact-finding’ trip; Qantas tops airline punctuality table
The Guardian·7h ago

STAT+: FDA finalists under review
STAT·14h ago

STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·15h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.